Ben McDonald, the country president of AstraZeneca Australia and New Zealand, stated that the findings demonstrate the opportunity Australia has to reduce the health and economic burden of chronic kidney disease.
Early intervention on chronic kidney disease would deliver economic boost
June 8, 2025 Latest NewsBioPharma
Latest Video
New Stories
-
Mesoblast updates investors on the succesful US launch of cell medicine
July 20, 2025 - - Australian Biotech -
Australian researcher awarded Gilead Sciences global grant to explore novel approach in breast cancer
July 18, 2025 - - Latest News -
The 'Dispatched' Week in Review Podcast - 17 July
July 17, 2025 - - Podcast -
Another day, another confusing response to the threat of US tariffs
July 17, 2025 - - Latest News -
NDIS keeps growing but signs emerge that reforms are starting to work
July 17, 2025 - - Latest News -
USTR launches new investigation, with minimal ambition on pharmaceuticals
July 17, 2025 - - Latest News -
New Zealand starting to benefit after lifting advertising prohibition
July 17, 2025 - - Latest News